Dr. Laurel Williams, DVM
Associate Professor, Oncology
Phone: 919.513.6477
Fax: 919.513.6830
Email: laurel_williams@ncsu.edu
Education
Doctor of Veterinary Medicine, University of Minnesota
Diplomate, American College of Veterinary Internal Medicine (Oncology)
Professional Experience & Qualifications
Associate Professor, North Carolina State University, 2005 – present
Assistant Professor, North Carolina State University, 2001 – 2005
Clinical Assistant Professor, North Carolina State University, 1999 – 2001
Visiting Clinical Instructor, North Carolina State University, 1998 – 1999
Research Fellowship, University of Minnesota, 1998
Residency, Tufts University, 1995 – 1997
Internship, Purdue University, 1994-1995
Research Area
Canine osteosarcoma; Canine and feline lymphoma; Mast cell tumors; Anti-angiogenic therapies; Targeted therapy and novel treatment modalities
Selected Publications
BM Pressler, LE Williams, JA Ramos-Vara. KI Anderson. Sequencing of the von Hippel-Lindau gene in canine renal carcinoma. J Vet Intern Med 2009;23(3):592-597.
KR Hume, J Johnson, LE Williams. Adverse effects of concurrent carboplatin chemotherapy and radiation therapy in dogs. J Vet Intern Med 2009;23(1):24-30.
KM Rassnick, LE Williams, O Kristal, R Al-SArraf, JL Baez, CH Zwahlen, G Dank. CCNU (lomustine) for treatment of mast cell tumors in cats: 38 cases (1999-2005). J Am Vet Med Assoc 2008;232(8):1200-1205.
AW Duncan, HS Marr, AJ Birkenheuer, RG Maggi, LE Williams, MT Correa, EB Breitschwerdt. Bartonella DNA in the blood and lymph nodes of Golden Retrievers with lymphoma and in healthy controls. J Vet Intern Med 2008;22(1):89-95.
A Vaughan, J Johnson, LE Williams. The impact of chemotherapeutic dose intensity and hematologic toxicity on first remission duration in dogs with lymphoma treated with a chemoradiotherapy protocol. J Vet Intern Med 2007;21(6)1332-1339.
M Boss, LE Williams. What is your diagnosis? J Am Vet Med Assoc 2007;230(7):995-996.
L Williams, J Nettifee Osborne, J Johnson. A model for improving student confidence and proficiency in diagnostic sample collection and interpretation. J Vet Med Educ 2006;33(1):132-139.
LE Williams, KM Rassnick, HT Power, SE Lana, KE Morrison-Collister, K Hansen, JL Johnson. CCNU in the treatment of canine epitheliotropic lymphoma . J Vet Intern Med 2006;20(1):136-143.
LE Williams, M Tcheng Broussard, JL Johnson, J Neel. Comparison of results of clinicians' assessments, cytologic examination of fine-needle lymph node aspirates, and flow cytometry for determination of remission status of lymphoma in dogs. J Am Vet Med Assoc 2005;226(4):562-566.
DE Thrall, SM LaRue, D Yu, T Samulski, L Sanders, B Case, G Rosner, C Azuma, J Poulson, AF Pruitt, W Stanley, ML Hauck, L Williams, P Hess, MW Dewhisrt. Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clin Cancer Res 2005;11(14):5206-5214.
LE Williams, JL Johnson, ML Hauck, DM Ruslander, GS Price, DE Thrall. Chemotherapy followed by half-body radiation therapy for canine lymphoma. J Vet Intern Med 2004;18(5):703-709.
LE Williams, JM Gliatto, RK Dodge, RM Gamblin, DH Thamm, SE Lana, M Szymkowski, AS Moore. Canine carcinoma of the apocrine glands of the anal sac: 113 cases (1985-1995). J Am Vet Med Assoc 2003;223(6):825-831.
LE Williams, RA Packer. Association between lymph node size and metastasis in dogs with oral malignant melanoma: 100 cases (1987-2001). J Am Vet Med Assoc 2003;222(9):1234-1236.
D Bailey, H Erb, L Williams, D Ruslander, M Hauck. Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular osteosarcoma in the dog. J Vet Intern Med 2003; 17(2):199-205.
DR Proulx, DM Ruslander, RK Dodge, ML Hauck, LE Williams, B Horn, GS Price, DE Thrall. A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation. Vet Radiol Ultrasound 2003;44(3):352-359.
KE Morrison-Collister, KM Rassnick, NC Northrup, O Kristal, JD Chretin, LE Williams, SM Cotter, AS Moore. A combination chemotherapy protocol with MOPP and CCNU consolidation (Tufts VELCAP-SC) for the treatment of canine lymphoma. Vet and Comp Oncol 2003:1(4);180-190.
T Kobayashi, ML Hauck, R Dodge, RL Page, GS Price, LE Williams, EM Hardie, KG Mathews, DE Thrall. Preoperative radiotherapy for vaccine associated sarcoma in 92 cats. Vet Rad Ultrasound 2002; 43(5):473-479.
LE Williams, N Banerji, JS Klausner, V Kapur, S Kanjilal. Establishment of two vaccine-associated feline sarcoma cell lines and determination of in vitro chemosensitivity to doxorubicin and mitoxantrone. Am J Vet Res 2001;62(9):1354-1357.
AS Moore, SM Cotter, WM Rand, CA Wood, LE Williams, CA London, AE Frimberger, DA L'Heureux. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma. J Vet Intern Med 2001;15(4):348-354.
KM Rassnick, TL Gieger, LE Williams, DM Ruslander, NC Northrup, O Kristal, NC Myers, AS Moore. Phase I evaluation of CCNU (lomustine) in tumor-bearing cats. J Vet Intern Med 2001;15(3):196-199.
KM Rassnick, AE Frimberger, CA Wood, LE Williams, SM Cotter, AS Moore. Evaluation of ifosfamide for treatment of various canine neoplasms. J Vet Intern Med 2000;14(3):271-6.
KM Rassnick, AS Moore, LE Williams, CA London, PP Kintzer, SJ Engler, SM Cotter. Treatment of canine mast cell tumors with CCNU. J Vet Intern Med 1999;13(6):601-5.
AS Moore, CA London, CA Wood, LE Williams, SM Cotter, DA L'Heureux, AE Frimberger. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. J Vet Intern Med 1999;13(5):395-8.
LE Williams, SM Cotter. Avoiding chemotherapeutic toxicoses in veterinary cancer patients. Veterinary Forum 1998;15(6): 44-52.